NCT00506259View on ClinicalTrials.gov

Treatment Strategies for Children With Smith-Magenis Syndrome

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 17, 2007

Primary Completion Date

May 22, 2018

Study Completion Date

May 22, 2018

Conditions
Developmental Delay DisordersChromosome DeletionMental RetardationSleep Disorders, Circadian RhythmSelf Injurious Behavior
Interventions
DRUG

dTR Melatonin (NIH CC PDS)

DEVICE

Phototherapy (Bright Light)

DRUG

Melatonin CR

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Human Genome Research Institute (NHGRI)

NIH

NCT00506259 - Treatment Strategies for Children With Smith-Magenis Syndrome | Biotech Hunter | Biotech Hunter